Takashi Moritoyo
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Anti-Inflammatory Thrombolytic JX10 (TMS-007) in Late Presentation of Acute Ischemic Stroke.
Journal: Stroke
Published: November 07, 2024
Causality Assessment Between Drugs and Fatal Cerebral Haemorrhage Using Electronic Medical Records: Comparative Evaluation of Disease-Specific and Conventional Methods.
Journal: Drugs - real world outcomes
Published: December 13, 2023
Antiviral effect and safety of nafamostat mesilate in patients with mild early-onset COVID-19: An exploratory multicentre randomized controlled clinical trial.
Journal: International journal of antimicrobial agents
Published: March 28, 2023
High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial.
Journal: EClinicalMedicine
Published: February 15, 2023
Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: November 25, 2022
Efficacy of l-Arginine treatment in patients with HTLV-1-associated neurological disease.
Journal: Annals of clinical and translational neurology
Published: September 29, 2022
A first-in-human study of the anti-inflammatory profibrinolytic TMS-007, an SMTP family triprenyl phenol.
Journal: British journal of clinical pharmacology
Published: September 25, 2022
(6)Development of Translational Research and Clinical Research Support Systems in Academia
Journal: No shinkei geka. Neurological surgery
Published: July 31, 2019
A Novel Method to Estimate Long-Term Chronological Changes From Fragmented Observations in Disease Progression.
Journal: Clinical pharmacology and therapeutics
Published: March 06, 2018
Effect of short-term treatment with sitagliptin or glibenclamide on daily glucose fluctuation in drug-naïve Japanese patients with type 2 diabetes mellitus.
Journal: Diabetes, obesity & metabolism
Published: January 18, 2018
Notable Drug-Drug Interaction Between Etizolam and Itraconazole in Poor Metabolizers of Cytochrome P450 2C19.
Journal: Journal of clinical pharmacology
Published: February 17, 2017
Accelerating Regulatory Science Initiatives for the Development of Drugs for Alzheimer's Disease in Japan.
Journal: Clinical therapeutics
Published: February 03, 2015
Last Updated: 09/26/2026